| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000040388 |
| Receipt No. | R000046088 |
| Scientific Title | A study on risk stratification of chronic diseases (hypertension, diabetes, arteriosclerosis) in users of welfare facilities for persons with disabilities and chronic disease management program for high-risk groups |
| Date of disclosure of the study information | 2020/05/15 |
| Last modified on | 2020/05/13 (Ver. 1) |
| Basic information | ||
| Public title | A study on chronic disease management program for users of welfare facilities for persons with disabilities | |
| Acronym | A study on chronic disease management program for users of welfare facilities for persons with disabilities | |
| Scientific Title | A study on risk stratification of chronic diseases (hypertension, diabetes, arteriosclerosis) in users of welfare facilities for persons with disabilities and chronic disease management program for high-risk groups | |
| Scientific Title:Acronym | A study on risk stratification of chronic diseases in users of welfare facilities for persons with disabilities and chronic disease management program for high-risk groups | |
| Region |
|
|
| Condition | ||
| Condition | Nursing | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to stratify the risk of chronic diseases (hypertension, diabetes, arteriosclerosis) for persons with disabilities in welfare facilities, and implement a chronic disease management program for high-risk groups. It is to verify the effectiveness. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Achievement rate (diet therapy, exercise therapy, medication compliance, smoking, drinking) |
| Key secondary outcomes | Blood pressure
Complication of heart disease and cerebrovascular disease Blood sugar level (fasting, 2 hours after meal) Development of diabetic complications Measurement of arteriosclerosis Progression of arteriosclerosis weight, BMI, waist circumference Urinalysis (urine sugar) Number of hospitalizations Type and amount of drug QOL scale score (SF-8) Degree of forgetting to take medication Number of visits / rate Social support |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | One chronic disease management program for users of welfare facilities
Biweekly for six months, total twelve times |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects are men and women between the ages of 20 and 75, and those with disabilities (neurocognitive disorders, intellectual disability, mental disorders) attending welfare facilities for persons with disabilities and those who have consented to participate in the study | |||
| Key exclusion criteria | Exclude any of the following cases.
Those who cannot communicate Those who cannot answer questions due to disabilities or mental illness Person who did not get consent from the legal representative (family or agent) |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hokkaido University | ||||||
| Division name | Faculty of Health Science | ||||||
| Zip code | 060-0812 | ||||||
| Address | five, Nishi, Kita-ku, Sapporo-shi, Hokkaido, Japan | ||||||
| TEL | 070-3875-3714 | ||||||
| harvester.20101001@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hokkaido University | ||||||
| Division name | Faculty of Health Science | ||||||
| Zip code | 060-0812 | ||||||
| Address | five, Nishi, Kita-ku, Sapporo-shi, Hokkaido, Japan | ||||||
| TEL | 070-3875-3714 | ||||||
| Homepage URL | |||||||
| harvester.20101001@gmail.com | |||||||
| Sponsor | |
| Institute | Hokkaido University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | MEXT |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Hokkaido University of Science |
| Name of secondary funder(s) | Nursing Consultant harvester |
| IRB Contact (For public release) | |
| Organization | Faculty of Health Science, Hokkaido University |
| Address | five, Nishi, Kita-ku, Sapporo-shi, Hokkaido, Japan |
| Tel | 090-6216-2084 |
| harvester.20101001@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046088 |